SAB Biotherapeutics Inc (SABSW) financials · $860.0K cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
SAB Biotherapeutics Inc (SABSW) $860.0K cap.
| Line | FY2025 | FY2023 |
|---|---|---|
| Revenue | N/A | $2.24M |
| Operating Income | -$49.0M | -$38.1M |
| Net Income | $13.3M | -$42.2M |
| EPS (Diluted) | -$0.79 | -$7.64 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $172.8M | $44.2M |
| Current Assets | $101.1M | $23.8M |
| Cash & Equivalents | $10.5M | $8.90M |
| PP&E | $13.3M | $15.4M |
| Total Liabilities | $21.3M | $18.2M |
| Current Liabilities | $10.7M | $7.98M |
| Shareholders' Equity | $151.5M | $26.0M |
| Retained Earnings | -$110.9M | -$124.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$44.8M | -$34.3M |
| CapEx | $933.2K | $337.3K |
| Investing Cash Flow | -$121.7M | -$12.0M |
| Financing Cash Flow | $168.3M | -$1.17M |
| Net Change in Cash | $1.60M | -$47.7M |
| Free Cash Flow | -$45.7M | -$34.6M |
FAQ
What is SABSW P/E and revenue?
SAB Biotherapeutics Inc (SABSW) $860.0K cap.
What is SABSW revenue?
SABSW income-statement cache has no revenue figure yet.
Is SABSW profitable?
SAB Biotherapeutics Inc last cached net income is $13.3M (FY2025).
What are SABSW total assets?
SAB Biotherapeutics Inc last cached total assets are $172.8M (FY2025).
What is SABSW free cash flow?
SAB Biotherapeutics Inc last cached free cash flow is -$45.7M (FY2025).
Not investment advice. Cached statements, not a live tape.